Drug Therapy Problems among Patients with both Cardiovascular Diseases and Diabetes Mellitus in a Sub-Saharan African Referral Hospital
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2021, Vol 5, Issue 1
Abstract
Background: Patients with both type 2 diabetes mellitus and cardiovascular disease receive multiple medications but there are limited studies on drug therapy problems among them in Sub-Saharan Africa. Objective: To determine the predictors of drug therapy problems among adult patients with both type 2 diabetes and cardiovascular diseases. Setting: Kenyatta National Hospital. Method: A cross-sectional study involving 180 adult patients with both comorbidities was conducted. Data collected included sociodemographic and clinical characteristics, medications prescribed and drug therapy problems. Data was analyzed using STATA v.13 at p<0.05. Main outcome measures: Drug therapy problems and their predictors. Results: Majority (91.1%) of the patients had at least one drug therapy problems; most common being untreated indication, 87 (48.3%) which was significantly associated with furosemide use (p=0.003) and >72 months living with diabetes (p=0.007). Non-adherence was associated with the perception of disease control or cure (p<0.001). Under dosing of medications was significant in poor glycemic control (=<0.001) and poor blood pressure control (p=0.012). Conclusion: Clinicians should be aware that patients with both comorbidities are more likely to be under dosed, non-adhere to treatment or have other untreated conditions. Recommendation for Practice • Health care practitioners need to continuously monitor the drug therapy problems among patients with comorbidities • Prescribers should holistically manage patients specifically by identification of untreated conditions • Diabetic hypertensive patients who are not responding to treatment should always be assessed for under dosing and nonadherence • Kenyatta National Hospital should be encouraged to have counseling programs, especially to patients with long standing comorbidities, to improve adherence.
Authors and Affiliations
Mugane GN*, Ndemo F and Nyamu D
Keywords
Related Articles
- EP ID EP748550
- DOI 10.23880/oajpr-16000232
- Views 100
- Downloads 0
Impact of GST on Pharmaceuticals An Overview
GST also known as the goods and service tax is defined as the giant tax structure designed to support and enhances the economic growth of our country. More than 150 countries have implemented GST so far. GST is an indire...
Systematic Review on the Potential of Pharmaceutical Intervention in Relation to Financial Resources Saving for Health System
Drug-Related Problems (DRP) generate extra spending on public health resources [1,2]. Pharmacoeconomic analysis allow the elaboration of preventive actions that avoid DRP and reduce costs in order to produce a positive i...
Algae Therapy: Highlights on the Pharmaceutical Potentials of Algae
The markets for prescribed drugs are growing quickly worldwide. A developing share of today’s promising pharmaceutical research focuses on the manufacturing of effective bioactive compounds from algae. Pharmaceutically...
Generation (Wh) Y; The Digital Face of Pharmaceutical Education
The undergraduate population in pharmaceutical science is now more diverse than ever before, presenting considerable teaching challenges as educators are faced with increasing student numbers, lack of space availability...
In Vitro Antimicrobial Activity of Chlorine Effervescent Tablets against Some Pathogenic Bacteria and Fungi
Objectives: The objective of the present study was to evaluate the antimicrobial activity of available choline (sodium dichloroisocyanurate (NaDCC) ) effervescent tablet solutions. Methods: Four bacteria and one fungi...